Financhill
Back

Pacific Biosciences of California 10K Form

Sell
21

PACB
Pacific Biosciences of California

Last Price:
$1.22
Seasonality Move:
-13.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive PACB News And Ratings

See the #1 stock for the next 7 days that we like better than PACB

PACB Financial Statistics

Sales & Book Value

Annual Sales: $154M
Cash Flow: $-44.7M
Price / Cash Flow: 0
Annual Sales: $1.73
Price / Book: 0.71

Profitability

EPS (TTM): -1.64000
Net Income (TTM): $-308.7M
Gross Margin: $37.3M
Return on Equity: -55.04%
Return on Assets: -20.21%

Key Pacific Biosciences of California Financial Ratios

  • The Gross Profit Margin over the past 18 years for PACB is 24.21%.
  • The Selling, General & Administrative Expenses for PACB have been equal to 113.64% of Gross Profit Margin.
  • The Research & Development expenses have been 87.60% of Revenue.
  • The Net Earning history of PACB is -200.40% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 10 years.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: PACB
CUSIP: 69404D
Website: pacb.com

Debt

Debt-to-Equity Ratio: 1.28
Current Ratio: 8.43
Quick Ratio: 7.08

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PACB Technical Analysis vs Fundamental Analysis

Sell
21
Pacific Biosciences of California (PACB) is a Sell

Is Pacific Biosciences of California a Buy or a Sell?